Tivic Health Systems Income from Continuous Operations 2020-2025 | TIVC

Tivic Health Systems income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Tivic Health Systems Annual Income from Continuous Operations
(Millions of US $)
2024 $0
2023 $0
2022 $-10
2021 $-8
2020 $-4
2019 $-4
Tivic Health Systems Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-2
2024-12-31
2024-09-30 $-1
2024-06-30 $-1
2024-03-31 $-1
2023-12-31
2023-09-30 $-2
2023-06-30 $-2
2023-03-31 $-2
2022-12-31 $-2
2022-09-30 $-3
2022-06-30 $-3
2022-03-31 $-2
2021-12-31 $-4
2021-09-30 $-2
2021-06-30 $-1
2021-03-31 $-1
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.001B
Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.084B 57.36
Doximity (DOCS) United States $11.307B 52.35
Hims & Hers Health (HIMS) United States $10.719B 111.37
Tempus AI (TEM) United States $9.847B 0.00
IRhythm Technologies (IRTC) United States $4.340B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.717B 0.00
Privia Health (PRVA) United States $2.496B 170.58
Enovis (ENOV) United States $1.944B 10.84
Phreesia (PHR) United States $1.590B 0.00
10x Genomics (TXG) United States $1.576B 0.00
Schrodinger (SDGR) United States $1.542B 0.00
Azenta (AZTA) United States $1.532B 71.21
Clover Health Investments (CLOV) United States $1.486B 0.00
Omnicell (OMCL) United States $1.344B 23.71
Evolent Health (EVH) United States $1.313B 111.80
Claritev (CTEV) United States $0.761B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.501B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.442B 132.00
Outset Medical (OM) United States $0.344B 0.00
TruBridge (TBRG) United States $0.331B 735.33
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Zepp Health (ZEPP) Netherlands $0.150B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.101B 3.84
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.068B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00